These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 2773304

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Plasma heparin values and hemostasis in equids after subcutaneous administration of low-dose calcium heparin.
    Gerhards H, Eberhardt C.
    Am J Vet Res; 1988 Jan; 49(1):13-8. PubMed ID: 3354959
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics and pharmacodynamics of a therapeutic dose of unfractionated heparin (200 U/kg) administered subcutaneously or intravenously to healthy dogs.
    Diquélou A, Barbaste C, Gabaig AM, Trumel C, Abella-Bourges N, Guelfi JF, Bousquet Mélou A.
    Vet Clin Pathol; 2005 Sep; 34(3):237-42. PubMed ID: 16134071
    [Abstract] [Full Text] [Related]

  • 6. Effect of sodium heparin and antithrombin III concentration on activated partial thromboplastin time in the dog.
    Hellebrekers LJ, Slappendel RJ, van den Brom WE.
    Am J Vet Res; 1985 Jul; 46(7):1460-2. PubMed ID: 4026027
    [Abstract] [Full Text] [Related]

  • 7. Amidolytic heparin activity and values for several hemostatic variables after repeated subcutaneous administration of high doses of a low molecular weight heparin in healthy dogs.
    Mischke R, Grebe S, Jacobs C, Kietzmann M.
    Am J Vet Res; 2001 Apr; 62(4):595-8. PubMed ID: 11327470
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Monitoring of heparin treatment. Comparison of thrombin time, activated partial thromboplastin time, and plasma heparin concentration, and analysis of the behavior of antithrombin III.
    Bounameaux H, Marbet GA, Lämmle B, Eichlisberger R, Duckert F.
    Am J Clin Pathol; 1980 Jul; 74(1):68-73. PubMed ID: 7395817
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Enzyme-linked immunosorbent assay for thrombin-antithrombin III complexes in horses.
    Topper MJ, Prasse KW, Morris MJ, Duncan A, Crowe NA.
    Am J Vet Res; 1996 Apr; 57(4):427-31. PubMed ID: 8712502
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Automated spectrophotometric heparin assays. Comparison of methods.
    van Putten J, van de Ruit M, Beunis M, Hemker HC.
    Haemostasis; 1984 Apr; 14(2):195-204. PubMed ID: 6735277
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.
    Granger CB, Becker R, Tracy RP, Califf RM, Topol EJ, Pieper KS, Ross AM, Roth S, Lambrew C, Bovill EG.
    J Am Coll Cardiol; 1998 Mar 01; 31(3):497-505. PubMed ID: 9502626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.